F.D.A. Approves New Obesity Drug That Will Compete With Wegovy

Health
By Gina Kolata from NYT Health https://ift.tt/OTpngq6
via IFTTT your-feed-science, Drugs (Pharmaceuticals), Semaglutide (Drug), Obesity, Weight Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women